These authors demonstrated that Nutlin-3 was able to reactivate p53 and reduced viability in several models of conjunctival melanoma, both in vitro in cell lines and 3D spheroids, as well as in vivo in zebrafish xenografts (60). This evidence concerns the gene TP53 and malignant conjunctival melanoma.